Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.
Publication
, Conference
Taplin, ME; George, DJ; Halabi, S; Sellers, WR; Sanford, B; Hennessy, KT; Mihos, GG; Small, EJ; Kantoff, PW
Published in: JOURNAL OF CLINICAL ONCOLOGY
July 15, 2004
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
July 15, 2004
Volume
22
Issue
14
Start / End Page
396S / 396S
Location
New Orleans, LA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Taplin, M. E., George, D. J., Halabi, S., Sellers, W. R., Sanford, B., Hennessy, K. T., … Kantoff, P. W. (2004). Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 22, pp. 396S-396S). New Orleans, LA: AMER SOC CLINICAL ONCOLOGY.
Taplin, M. E., D. J. George, S. Halabi, W. R. Sellers, B. Sanford, K. T. Hennessy, G. G. Mihos, E. J. Small, and P. W. Kantoff. “Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.” In JOURNAL OF CLINICAL ONCOLOGY, 22:396S-396S. AMER SOC CLINICAL ONCOLOGY, 2004.
Taplin ME, George DJ, Halabi S, Sellers WR, Sanford B, Hennessy KT, et al. Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 396S-396S.
Taplin, M. E., et al. “Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480.” JOURNAL OF CLINICAL ONCOLOGY, vol. 22, no. 14, AMER SOC CLINICAL ONCOLOGY, 2004, pp. 396S-396S.
Taplin ME, George DJ, Halabi S, Sellers WR, Sanford B, Hennessy KT, Mihos GG, Small EJ, Kantoff PW. Prognostic significance of plasma chromogranin A levels in hormone-refractory prostate cancer patients treated an Cancer and Leukemia Group B (CALGB) 9480. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2004. p. 396S-396S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
July 15, 2004
Volume
22
Issue
14
Start / End Page
396S / 396S
Location
New Orleans, LA
Publisher
AMER SOC CLINICAL ONCOLOGY
Conference Name
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences